Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Provoked Vestibulodynia
NCT04057755Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2016
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vestibulodynia comparing Botox Arm with Placebo Arm (2 arms). Primary endpoint: Self-reported dyspareunia at 6 months. Started May 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on NCT04057755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057755.